Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
BEFREE |
GCK-MODY in the US Monogenic Diabetes Registry: Description of 27 unpublished variants.
|
31063852 |
2019 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Almost 20 years after the first report of NEUROD1-MODY, only a few families in Europe and Asia had shown mutations in NEUROD1 as the cause of monogenic diabetes.
|
31578821 |
2019 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Maturity onset diabetes of the young due to <i>HNF1A</i> mutations (HNF1A-MODY) is the most frequent form of monogenic diabetes in adults.
|
29666556 |
2018 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Hyperinsulinemic glucose clamps were performed to examine counter-regulatory responses to controlled hypoglycemic challenges created in humans with monogenic diabetes resulting from heterozygous glucokinase mutations (GCK-MODY).
|
30146176 |
2018 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Most (6/7) patients with HNF4A variants rapidly failed TODAY treatment across study arms (hazard ratio = 5.03, P = 0.0002), while none with GCK variants failed treatment.ConclusionThe finding of 4.5% of patients with monogenic diabetes in an overweight/obese cohort of children and adolescents with T2D suggests that monogenic diabetes diagnosis should be considered in children and adolescents without diabetes-associated autoantibodies and maintained C-peptide, regardless of BMI, as it may direct appropriate clinical management.
|
29758564 |
2018 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The true frequency of MD in the overall population may be higher given later onset of reportedly more frequent types of MD than GCK -MODY.
|
28436179 |
2018 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
BEFREE |
MODY1 is a maturity-onset monogenic diabetes, caused by heterozygous mutations of the HNF4A gene.
|
28684784 |
2017 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
BEFREE |
Glucokinase monogenic diabetes (GCK-maturity-onset diabetes of the young [MODY]) should be differentiated from gestational diabetes mellitus (GDM) because management differs.
|
26109503 |
2016 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
BEFREE |
GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated.
|
27106716 |
2016 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The Common p.R114W HNF4A Mutation Causes a Distinct Clinical Subtype of Monogenic Diabetes.
|
27486234 |
2016 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Rare and non-silent variants in 29 genes known to cause monogenic diabetes, including 12 maturity-onset diabetes of the young (MODY) genes, were investigated for pathogenicity.
|
27810688 |
2016 |
Monogenic diabetes
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
In Central Europe, 17-25% of patients with monogenic diabetes (maturity-onset diabetes of the young, MODY) transiently express islet cell autoantibodies.
|
25896041 |
2015 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The study group included 129 children with GCK-MODY from the Polish Registry of Monogenic Diabetes and 395 with type 1 diabetes (T1DM), in whom we genotyped 2 SNPs in G6PC2 (rs560887) and GCKR (rs1260326).
|
24918535 |
2014 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
CLINGEN |
Parents were screened for HNF4A mutations post-diagnosis and one father was subsequently found to have maturity-onset diabetes of the young.
|
23796040 |
2014 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Finally, we searched the Norwegian MODY Registry for children with genetically verified MD.
|
23624530 |
2013 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
BEFREE |
The prevalence of MD was stable at between 4.2 and 4.6/100,000 children, accounting for 3.1-4.2% of children with diabetes, with glucokinase (GCK)-MODY being the most frequent type, amounting to 83% of patients with MD.
|
22782286 |
2012 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Inactivating mutations in HNF1A and HNF4A cause the maturity-onset diabetes of youth (MODY)-3 and MODY1 forms of monogenic diabetes, respectively.
|
22802087 |
2012 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
We determined the rs560887 genotype of patients with monogenic diabetes and glucokinase gene mutations (GCK-MODY) and correlated the genotypes with HbA(1c) levels.
|
22486180 |
2012 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
CLINGEN |
Here we report the identification of MED25 as one of the HNF4α binding partners in pancreatic ß-cells leading to insulin secretion which is impaired in MODY patients.
|
22952853 |
2012 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
BEFREE |
HDL cholesterol levels measured in individuals with likely monogenic diabetes may be useful in screening for GCK-MODY and differentiation from T1DM and HNF1A-MODY, regardless of treatment or metabolic control.
|
21521320 |
2011 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
CLINGEN |
The phenotype associated with heterozygous HNF4A gene mutations has recently been extended to include diazoxide responsive neonatal hypoglycemia in addition to maturity-onset diabetes of the young (MODY).
|
20164212 |
2010 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Neonatal hyperinsulinaemic hypoglycaemia and monogenic diabetes due to a heterozygous mutation of the HNF4A gene.
|
19566570 |
2009 |
Monogenic diabetes
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The most frequently diagnosed forms of monogenic diabetes are MODY, mitochondrial diabetes, permanent and transient neonatal diabetes (PNDM and TNDM).
|
19010562 |
2008 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
BEFREE |
This concept, first advanced with the discovery and physiological characterisation of various genetic subtypes of MODY, has been extended to other forms of monogenic diabetes (e.g. neonatal diabetes).
|
18504548 |
2008 |
Monogenic diabetes
|
0.600 |
Biomarker
|
disease |
CLINGEN |
Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.
|
17407387 |
2007 |